Friday 6 November 2026
Export MEDP’s income statement to Excel — free account
Medpace Holdings, Inc.
MEDP Healthcare Diagnostics & Research
Medpace Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 20.0% from fiscal 2024.
- Revenue
- +8.50%
- EPS
- +24.6%
- Free cash flow
- −16.6%
Quarter to September 2026, against a year earlier
652.89
17.91
+2.82%
Follow MEDP
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
9 | 9 | 9 | 8 |
+8 more TTM periods Free account |
| 117.88% | 162.15% | 77.25% | 70.23% | ||
| 25.54% | 27.09% | 22.87% | 22.13% | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(680.52%) | (215.54%) | (663.29%) | (202.23%) | |
Average Days of Receivables |
57.56 | 57.96 | 53.77 | 58.00 | |
Free Cash Flow per Share |
23.90 | 25.08 | 25.00 | 23.64 | |
Free Cash Flow |
667.63 | 706.69 | 711.00 | 681.87 | |
Capital Expenditures |
(55.42) | (45.97) | (28.18) | (31.36) | |
| Other line items | |||||
Cash ROIC |
51.74% | 75.46% | 56.83% | 71.32% | |
Accounts Receivable Turnover |
6.92 | 6.79 | 7.73 | 7.24 | |
Accounts Payable Turnover |
22.44 | 19.04 | 15.72 | 24.13 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
20.24 | 17.80 | 16.70 | 14.03 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.17) | (0.18) | (0.19) | (0.17) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
6.79% | 6.79% | 7.00% | 7.81% | |
Share Based Compensation of Revenue |
0.79% | 0.76% | 0.85% | 1.37% | |
Interest Coverage |
(31.66) | (38.03) | (49.23) | (41.86) | |
Operating CF/Net income |
1.40 | 1.53 | 1.61 | 1.58 | |
Depreciation/Fixed assets |
0.16 | 0.18 | 0.21 | 0.21 | |
Capex/Depreciation |
(2.03) | (1.65) | (1.00) | (1.11) | |
Revenue per Share |
101.59 | 98.75 | 94.16 | 87.72 | |
Operating CF per Share |
25.88 | 26.71 | 25.99 | 24.73 | |
Capex per Share |
(1.98) | (1.63) | (0.99) | (1.09) | |
Capex to Sales |
0.02 | 0.02 | 0.01 | 0.01 |
Columns are period end dates · fundamentals updated 2 Nov 2026